Results 291 to 300 of about 66,239 (358)

A real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province. [PDF]

J Pharm Policy Pract
Ma D, Chen C, Sun M, Chen J, Cheng W, Cao J, Xia M, Hu Y, Sun Z, Jia X, Yin Z.   +10 more
europepmc   +1 more source

Potential Clinical Use of CytoSorb^® for Ticagrelor and Rivaroxaban Elimination Prior to Emergency Orthopedic Surgery in Trauma Patients. [PDF]

Life (Basel)
Melegari G, Gazzotti F, Arturi F, Bertellini E, Tognù A, Santonastaso DP, Villani M, Coppi F, Fattorini F, Catani F, Barbieri A.   +10 more
europepmc   +1 more source

Evaluating the Effect of Concomitant Azoles on Anticoagulant Prescribing Practices in Transplant Patients: A National Survey of Clinicians. [PDF]

J Pharm Technol
Burroughs KM, Lichvar AB, Groetzinger LM, Horn E, Iasella CJ, Moore CA, Pierce DR, Sacha LM, Rivosecchi RM.   +8 more
europepmc   +1 more source

Outcomes of Different Regimens of Rivaroxaban and Aspirin in Cardiovascular Diseases: A Network Meta-Analysis. [PDF]

J Clin Med
Al-Salihi MM, Qureshi AI.
europepmc   +1 more source

Comparative risk of osteoporotic fractures with direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients: a systematic review. [PDF]

Int J Burns Trauma
Mojahedi A, Singh A, Sadeghian A, Chen O.   +3 more
europepmc   +1 more source

Comparative Risk of Major Bleeding With Concomitant Use of Oral Anticoagulants and Corticosteroid Bursts. [PDF]

Clin Transl Sci
Yao TC, Chang SM, Tsai YF, Chiang SJ, Tsai HJ.   +4 more
europepmc   +1 more source

Cost-effectiveness and budget impact analysis of switching from apixaban to rivaroxaban treatment among patients with nonvalvular atrial fibrillation in a German healthcare setting. [PDF]

J Comp Eff Res
Subash R, Strakosch T, Zhang M, Hagan M, Dworatzek E, Kisser A, Vasilopoulos V, Salter C, Dickerson C, Stawowczyk E.   +9 more
europepmc   +1 more source

Anticoagulantia, een veld in beweging [PDF]

, 2010
Christiaens, Thierry, De Backer, Tine
core  

Population pharmacokinetic analysis of rivaroxaban in healthy volunteers and patients with radiofrequency ablation of non-valvular atrial fibrillation in China. [PDF]

Front Pharmacol
Gu F, Tang K, Zhang C, Hu M, Sun J, Yu X, Tian M, Zhang C, Chen Y.   +8 more
europepmc   +1 more source

Tightening Our Belts in the New Healthcare Economy [PDF]

, 2013
Pizzi, Laura, PharmD,MPH
core   +1 more source